Managing multiple myeloma during the COVID-19 outbreak
Managing multiple myeloma during the COVID-19 outbreak
Treating TRK fusion cancer: Selecting between available agents
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
PRIAS: Active surveillance for men with low risk prostate cancer
Cancer genetics in the clinic: Ready for 'prime time'?
Identifying early stage colorectal cancer patients in Nigeria
Innovation in cervical cancer screening, treatment and elimination
Highlights from BGICC 2020
Ductal carcinoma in situ, are we over-treating it?
The age of genomic profiling
Prognostic impact of chromosomal abnormalities and copy number alterations in B-cell precursor ALL treated on UKALL14
Implementation of genetic testing in breast cancer patients